A Phase 1 Study of BAY80-6946 (Phosphatidylinositol 3'-Kinase Inhibitor) in Combination With Paclitaxel in Subjects With Advanced Solid Malignancy.

Trial Profile

A Phase 1 Study of BAY80-6946 (Phosphatidylinositol 3'-Kinase Inhibitor) in Combination With Paclitaxel in Subjects With Advanced Solid Malignancy.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jul 2015

At a glance

  • Drugs Copanlisib (Primary) ; Paclitaxel
  • Indications Breast cancer; Male breast cancer; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Bayer
  • Most Recent Events

    • 06 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Dec 2014 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Nov 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top